YOLFTbeta
Orexo AB

Orexo AB

ORX · ST · Healthcare / Drug Manufacturers - Specialty & Generic

0.877SEK+0.01 (+1.27%)

Price History

Full chart

Market Stats

Previous Close0.866
Open0.899
Day Range0.829 – 0.90
52-Week Range12.20 – 43.40
Volume1.15M
Market Cap470.70M
P/E (TTM)0.00
Forward P/E9.16
EPS-10.14
Dividend Yield0.00%
Beta0.86
50-Day Avg14.05
200-Day Avg21.38

About

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Nikolaj Sorensen
  • Employees61
  • HeadquartersVirdings allé 22, Uppsala, Sweden, Sweden
  • Websitehttps://www.orexo.com

Leadership

  • Mr. Nikolaj SorensenPresident & CEO · b. 1972
  • Mr. Fredrik JarrstenExecutive VP & CFO · b. 1967
  • Ms. Cecilia CouplandSenior VP & Head of Operations · b. 1976
  • Lena WangeInvestor Relations & Communications Director
  • Mr. Robert RonnSenior VP and Head of R&D · b. 1976
  • Dr. Edward Kim M.B.A., M.D.Senior VP & Chief Medical Officer
  • Ms. Lisa MooreSenior Vice President of Products & Portfolio Strategy
  • Ms. Raheleh NassajiSenior Vice President of Business Development

Financials

Income Statement

Currency: SEK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.96M21.36M86.72M62.35M131.96M76.76M233.35M236.10M210.50M199.61M326.28M429.36M570.32M643.34M705.80M643.70M783.10M844.80M663.60M565.00M624.30M638.80M590.00M26.00M
Growth (%)-+621.38%+305.97%-28.10%+111.63%-41.83%+204.01%+1.18%-10.84%-5.17%+63.45%+31.59%+32.83%+12.80%+9.71%-8.80%+21.66%+7.88%-21.45%-14.86%+10.50%+2.32%-7.64%-95.59%
Cost of Revenue1.66M2.52M1.93M-2.95M-11.15M-14.38M17.45M23.65M26.32M29.00M27.88M29.34M107.44M136.08M149.60M164.40M171.80M105.60M65.60M78.90M72.30M88.90M72.10M81.50M
Gross Profit1.30M18.84M84.78M65.31M143.11M14.38M215.90M212.45M184.18M170.62M298.40M400.01M462.87M507.26M556.20M479.30M611.30M739.20M598.00M486.10M552.00M549.90M517.90M-55.50M
Gross Margin43.87%88.21%97.77%104.74%108.45%18.74%92.52%89.98%87.50%85.47%91.46%93.17%81.16%78.85%78.80%74.46%78.06%87.50%90.11%86.04%88.42%86.08%87.78%-213.46%
Operating Expense1.24M18.54M84.11M109.87M183.70M194.95M328.40M311.54M265.95M562.12M377.81M539.70M487.88M676.24M504.50M421.90M515.50M508.00M620.10M700.20M735.90M659.40M658.20M291.40M
Operating Income57.00K299.00K672.00K-44.56M-40.59M-180.57M-112.50M-99.08M-81.77M-391.50M-79.41M-139.69M-25.01M-168.99M51.70M57.40M95.80M231.20M-22.10M-214.10M-183.90M-109.50M-140.30M-346.90M
Operating Margin1.93%1.40%0.77%-71.47%-30.76%-235.25%-48.21%-41.97%-38.85%-196.13%-24.34%-32.53%-4.38%-26.27%7.33%8.92%12.23%27.37%-3.33%-37.89%-29.46%-17.14%-23.78%-1334.23%
EBITDA21.34M26.58M15.48M-40.34M-29.52M-166.94M-92.76M-94.22M-46.55M-108.03M-57.95M-92.37M-12.22M-88.25M80.80M57.60M110.30M288.40M16.80M-141.30M-73.90M-22.10M58.60M-285.90M
EBITDA Margin720.70%124.43%17.86%-64.70%-22.37%-217.49%-39.75%-39.90%-22.12%-54.12%-17.76%-21.51%-2.14%-13.72%11.45%8.95%14.09%34.14%2.53%-25.01%-11.84%-3.46%9.93%-1099.62%
Net Income-20.80M-27.59M-15.94M-43.25M-32.94M--103.05M-98.08M-89.25M-392.01M-85.86M-154.94M-56.58M-197.99M29.00M23.20M137.90M219.10M-84.40M-223.50M-177.60M-128.30M-203.00M-129.80M
Net Income Margin-702.57%-129.18%-18.39%-69.36%-24.97%--44.16%-41.54%-42.40%-196.38%-26.32%-36.09%-9.92%-30.77%4.11%3.60%17.61%25.94%-12.72%-39.56%-28.45%-20.08%-34.41%-499.23%
R&D12.50M30.32M64.01M64.79M91.84M152.29M238.13M224.22M186.91M194.41M216.17M238.14M197.82M172.58M132.30M134.20M166.80M181.30M224.90M272.30M318.00M303.10M340.00M233.10M
R&D as % of Total Revenue422.26%141.94%73.82%103.91%69.60%198.41%102.05%94.96%88.80%97.39%66.25%55.47%34.69%26.83%18.74%20.85%21.30%21.46%33.89%48.19%50.94%47.45%57.63%896.54%
Interest Expense537.00K633.00K695.00K024.00K23.00K266.00K2.73M8.94M12.32M12.27M14.55M27.80M23.01M23.80M21.90M16.50M19.50M16.20M28.20M27.80M41.20M60.00M50.30M
Interest Expense % of Total Revenue18.14%2.96%0.80%0.00%0.02%0.03%0.11%1.15%4.25%6.17%3.76%3.39%4.88%3.58%3.37%3.40%2.11%2.31%2.44%4.99%4.45%6.45%10.17%193.46%

Balance Sheet

Currency: SEK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets33.25M45.15M106.02M371.31M379.93M801.87M702.02M649.33M712.69M546.10M481.75M772.33M1.23B1.02B1.02B1.00B1.29B1.50B1.23B1.27B1.11B786.60M594.80M1.30B
Total Liabilities7.73M9.27M26.58M32.40M55.58M130.62M132.24M100.67M244.45M235.00M290.56M610.87M770.86M749.85M708.50M674.80M810.60M794.70M674.40M924.10M915.10M727.70M721.10M812.20M
Total Equity25.52M35.88M79.44M338.91M324.35M671.25M569.78M548.66M468.24M311.10M191.19M161.46M455.02M266.46M310.30M329.10M476.10M706.40M558.50M349.60M193.90M58.90M-126.30M490.60M
Cash14.85M15.48M84.24M260.49M276.41M291.60M188.22M87.41M135.80M246.86M228.07M105.64M284.48M198.12M282.40M327.90M589.80M816.80M505.30M504.10M132.20M171.00M123.30M912.40M
Total Debt------9.51M79.77M94.42M114.51M113.57M104.08M493.76M494.33M397.80M319.20M320.60M344.30M291.00M550.50M539.60M473.80M476.00M492.20M
Net Debt-14.85M-15.48M-84.24M-260.49M-276.41M-291.60M-178.71M-7.65M-41.38M-132.35M-114.50M-1.56M209.28M296.21M115.40M-8.70M-269.20M-472.50M-214.30M46.40M407.40M302.80M352.70M-420.20M

Cash Flow

Currency: SEK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-20.80M-27.59M-15.94M-45.38M-25.28M-160.49M-101.49M-133.93M-42.97M-117.23M28.67M-263.20M-487.30M-102.19M156.20M146.60M242.00M287.00M16.80M-229.00M-156.60M-95.00M-32.70M173.00M
Investing Cash Flow-17.67M633.00K14.79M-81.26M28.14M173.19M-1.89M21.54M-3.44M-15.03M6.93M-107.50M-71.70M17.69M5.50M-1.60M-6.20M-22.40M-189.10M-52.90M-234.70M200.80M-5.30M635.90M
Financing Cash Flow41.00K-53.97M302.90M12.97M2.98M-16.09M95.19M243.76M-54.44M251.06M739.37M2.60M-90.60M-85.40M-53.70M-53.70M-111.30M250.60M-21.40M-70.10M-15.50M-2.30M
Capital Expenditure429.00K433.00K1.12M2.46M4.61M49.32M1.67M3.15M3.44M4.74M5.77M107.50M71.72M4.12M1.40M1.60M3.60M32.00M189.70M52.80M23.90M18.90M4.60M0
Free Cash Flow-21.23M-28.03M-17.06M-45.38M-25.28M-160.49M-103.16M-137.08M-46.41M-121.96M22.90M-370.71M-559.02M-106.31M154.80M145.00M238.40M255.00M-172.90M-281.80M-180.50M-113.90M-37.30M173.00M
FCF to OCF102.06%101.57%107.02%100.00%100.00%100.00%101.65%102.36%108.00%104.04%79.88%140.85%114.72%104.03%99.10%98.91%98.51%88.85%-1029.17%123.06%115.26%119.89%114.07%100.00%

Earnings

Report DateFeb 23, 2006Oct 18, 2006Feb 20, 2007May 9, 2007Oct 23, 2007Feb 15, 2008May 7, 2008Aug 14, 2008Nov 10, 2008Feb 17, 2009Aug 21, 2009Nov 10, 2009Feb 17, 2010May 5, 2010Aug 20, 2010Nov 10, 2010Feb 16, 2011May 4, 2011Aug 10, 2011Nov 9, 2011Jan 31, 2012Apr 27, 2012Jul 12, 2012Oct 25, 2012Jan 30, 2013Apr 26, 2013Jul 12, 2013Oct 23, 2013Jan 30, 2014Apr 25, 2014Jul 11, 2014Oct 22, 2014Jan 29, 2015Apr 23, 2015Jul 10, 2015Oct 22, 2015Jan 28, 2016Apr 21, 2016Jul 12, 2016Oct 20, 2016Jan 26, 2017Apr 21, 2017Jul 11, 2017Oct 19, 2017Jan 25, 2018Apr 26, 2018Jul 11, 2018Oct 25, 2018Jan 30, 2019May 2, 2019Jul 11, 2019Oct 24, 2019Jan 30, 2020Apr 28, 2020Jul 16, 2020Nov 4, 2020Jan 28, 2021Apr 29, 2021Jul 15, 2021Nov 3, 2021Jan 27, 2022Apr 28, 2022Jul 14, 2022Nov 3, 2022Jan 26, 2023Apr 27, 2023Jul 18, 2023Nov 2, 2023Feb 8, 2024May 8, 2024Jul 17, 2024Oct 24, 2024Feb 6, 2025May 6, 2025Jul 16, 2025Oct 23, 2025Feb 5, 2026Apr 28, 2026Jul 16, 2026Oct 22, 2026
EPS Estimate-2.30-1.200.47-3.06-4.152.20-3.173.370.06--1.561.60-1.77-1.83-1.25-0.95--0.48-0.62-0.57-0.56--0.30-0.18-0.481.63-0.64-1.43-1.06-1.722.33-0.38-0.13-0.43-1.32-1.69-1.80-3.00-0.80-0.50-0.20-0.90-0.700.500.50-0.700.471.511.85-0.230.882.102.501.200.47-0.760.14-1.20-1.55-1.60-1.10-0.20-1.20-1.68-2.15-2.33-0.92-0.92-0.92-0.40-0.40-0.75-1.63-1.17-0.37-0.50-0.30--1.60-2.10
EPS Actual-3.00-0.84-0.91-2.62-2.44-2.47-2.77-1.310.09-0.67-2.53-0.41-1.80-1.18-1.51-1.221.20-1.67-1.02-1.87-9.07-0.50-0.56-1.05-0.770.86-2.49-0.94-1.19-0.66-1.58-1.13-0.09-0.45-2.46-1.33-1.50-1.000.141.040.96-1.000.090.810.77-0.751.451.771.470.401.513.161.102.34-0.94-2.45-1.45-0.92-2.15-1.51-1.92-0.69-1.04-0.77-2.67-1.86-0.37-0.97-0.54-0.26-1.04-1.21-3.37-0.46-1.15-0.8620.88-3.81-2.53-
Surprise-30.43%30.00%-293.62%14.38%41.20%-212.27%12.62%-138.87%50.00%--62.18%-125.63%-1.69%35.52%-20.80%-28.42%--247.92%-64.52%-228.07%-1519.64%--86.67%-483.33%-60.42%-47.24%-289.06%34.27%-12.26%61.63%-167.81%-197.37%30.77%-4.65%-86.36%21.30%16.67%66.67%117.50%308.00%580.00%-11.11%112.86%62.00%54.00%-7.14%208.51%17.22%-20.54%273.91%71.59%50.48%-56.00%95.00%-300.00%-222.37%-1135.71%23.33%-38.71%5.63%-74.55%-245.00%13.33%54.17%-24.19%20.17%59.78%-5.43%41.30%35.00%-160.00%-61.33%-106.75%60.68%-210.81%-71.74%7061.47%--58.13%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours--Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap470.70M
Enterprise Value172.09M
Trailing P/E0.00
Forward P/E9.16
PEG Ratio13.07
Price / Sales28.61
Price / Book1.62
EPS-10.14
Book Value7.72
Revenue (TTM)16.60M
Gross Profit (TTM)6.30M
EBITDA-317.80M
Profit Margin2774.70%
Operating Margin-2945.71%
Return on Equity-1138.63%
Return on Assets-42.63%
Shares Outstanding35.13M
Shares Float22.55M
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 31, 20111904:1903